Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Applied Therapeutics, Inc. - Common Stock (NQ:APLT)

0.4445 +0.0043 (+0.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Applied Therapeutics, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Applied Therapeutics Reveals Pivotal Study Data In Hereditary Neuropathy
 
Via Benzinga
Applied Therapeutics Announces Positive Sorbitol Reduction Data From the Ongoing Phase 3 INSPIRE Trial in Sorbitol Dehydrogenase (SORD) Deficiency
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics to Present at the SVB Securities Global Biopharma Conference
From Applied Therapeutics
Via GlobeNewswire
Recap: Applied Therapeutics Q2 Earnings
  Applied Therapeutics (NASDAQ:APLT) reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why Applied Therapeutics Shares Are Seeing Blue Skies
Applied Therapeutics Inc (NASDAQ: APLT) shares are trading higher by 15.99% to $0.87 Wednesday morning after the company announced a partnership with Advanz Pharma for the commercialization of AT-007... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday! 
Via InvestorPlace
Applied Therapeutics Announces Partnership with Advanz Pharma for Commercialization of AT-007 (Govorestat) in Europe
From Applied Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Applied Therapeutics Reports Third Quarter 2022 Financial Results
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Announces Multiple Data Presentations at the American Heart Association Scientific Sessions November 5-7, 2022
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Announces Full Enrollment in the Registrational Phase 3 ARISE-HF Trial of AT-001 in Diabetic Cardiomyopathy
From Applied Therapeutics
Via GlobeNewswire
Helbiz And 3 Other Stocks Under $1 Insiders Are Aggressively Buying
The Dow Jones dropped by more than 400 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday
Gainers Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45. FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52. 
Via Benzinga
Why Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday's Mid-Day Session
Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) surged 77.7% to $9.35. 
Via Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday. 
Via Benzinga
Dow Dips Over 300 Points; Provention Bio Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 300 points on Thursday. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers 
Via Benzinga
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of... 
Via Benzinga
Nasdaq Edges Higher; AngioDynamics Shares Plummet
U.S. stocks pared losses midway through trading, with the Nasdaq Composite turning higher on Thursday. 
Via Benzinga
Applied Therapeutics' Lead Candidate Pediatric Study Failed To Reach Statistical Significance
Applied Therapeutics Inc's (NASDAQ: APLT) ACTION-Galactosemia Kids Phase 3 trial has demonstrated a trend in clinical benefit favoring AT-007 vs. placebo.  
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Statera BioPharma (NASDAQ:STAB) stock increased by 64.8% to $0.23 during Thursday's pre-market session. The company's market cap stands at $11.5 million. 
Via Benzinga
Applied Therapeutics Announces Positive Data Trend in AT-007 ACTION-Galactosemia Kids Pediatric Trial; Trial Will Continue to 18 Months in Blinded Format
From Applied Therapeutics
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to take a look at the biggest pre-market stock movers for Thursday and the news that's got those shares moving! 
Via InvestorPlace
TransDigm Group To $740? Also Check Out Some Other Major PT Changes
Wells Fargo raised the price target on TransDigm Group Incorporated (NYSE: TDG) from $620 to $740. Wells Fargo analyst Matthew Akers maintained an Overweight rating on the stock. TransDigm Group shares... 
Via Benzinga
Applied Therapeutics to Sponsor and Present at the 2022 Galactosemia Foundation Conference
From Applied Therapeutics
Via GlobeNewswire
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase... 
Via Benzinga
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.